We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
As colder weather arrives, the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Fire Chiefs Council (NFCC) are urging the public to be aware of fire risks linked to emollient skin creams.
Understanding gut microbiome interactions with medicines could help explain differences in how people respond to treatment and build on existing medicine safety knowledge to support safer, more effective prescribing in the f…
As the cold weather sets in and coughs and colds become more common, the MHRA is reminding people that small, everyday choices can make a big difference to winter wellbeing.
As with any medicine, the MHRA will keep the safety and effectiveness of lenacapavir under close review.
National Commission is seeking evidence to shape regulation of AI in healthcare and support the UK’s ambition for a world-leading, AI-enabled NHS
Updated MHRA guidance will help health institutions, such as NHS Trusts and Boards, safely design and make general medical devices for patients.
Exploring the MHRA's transformational impact on access, experience, and outcomes.
As with any medicine, the MHRA will keep the safety and effectiveness of depemokimab under close review.
As with any medicine, the MHRA will keep the safety and effectiveness of fluticasone propionate under close review.
This holiday season, the MHRA is reminding people that some common festive foods can interact with medicines, altering how well they work or increasing the risk of side effects.
Professor Benger’s leadership comes at a pivotal time as the MHRA and NICE deepen collaboration
Patients in the UK and Singapore could gain faster access to cutting-edge healthcare innovations under a new partnership bringing two globally respected regulators together with one of the world’s leading biotech creators.
Professor Anthony Harnden has congratulated the trio of Agency board members on the extension of their appointments.
As with any medicine, the MHRA will keep the safety and effectiveness of mirdametinib under close review.
Further support provided for innovative medicines as the rebate rate falls by more than third for 2026.
The MHRA and Northern Ireland partners are working together to support innovation, enhance patient safety and ensure people in Northern Ireland benefit from world-class regulation.
This holiday season, the MHRA is highlighting one of the most overlooked winter health risks: combining medicines with alcohol.
All babies in the UK get the hepatitis B vaccine. It has a well-established safety record and ensures long-term protection against the virus.
A story of hope, medical innovation, and the impact of effective regulation on access to treatment.
GP online access has been rolled out at nearly all GP practices, benefiting patients across England.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).